Philips (NYSE: PHG) schedules 2026 AGM on board roles, pay and dividend

Rhea-AI Filing Summary

Royal Philips is convening its 2026 Annual General Meeting of Shareholders on May 8, 2026 in Amsterdam. The agenda includes appointing John DeFord to the Supervisory Board, re-appointing three existing Supervisory Board members, and re-appointing Roy Jakobs as President/CEO and Chairman of the Board of Management.

Shareholders will also vote on a new Remuneration Policy for the Supervisory Board, the 2025 Remuneration Report (advisory vote), the 2025 financial statements, and a dividend in cash or shares. As background, Philips generated 2025 sales of EUR 18 billion and employs about 64,800 people in more than 100 countries.

Key Figures

AGM date and time: May 8, 2026, 10:00 CET 2025 sales: EUR 18 billion Employees: approximately 64,800 +2 more

5 metrics

AGM date and time May 8, 2026, 10:00 CET Annual General Meeting of Shareholders 2026 in Amsterdam

2025 sales EUR 18 billion Company-wide sales in 2025

Employees approximately 64,800 Global headcount across more than 100 countries

Supervisory Board nomination 1 new, 3 re-appointments John DeFord appointment; Stoffels, Verhagen, Poonen re-appointments

CEO mandate Re-appointment of Roy Jakobs Proposed as President/CEO and Chairman effective May 8, 2026

Key Terms

Annual General Meeting of Shareholders, Supervisory Board, Remuneration Policy, Remuneration Report, +1 more

5 terms

Annual General Meeting of Shareholders financial

"announced it has convened the Annual General Meeting of Shareholders (AGM) 2026"

Supervisory Board financial

"Proposal to appoint John DeFord ... as new member of the Supervisory Board"

A supervisory board is an independent oversight body that watches over a company’s executive managers, reviews strategy, approves major decisions, and hires or removes top executives. It acts like an impartial group of guardians or referees who make sure managers are running the business responsibly and within agreed rules. Investors care because strong oversight can reduce risks, improve accountability, and protect long‑term shareholder value.

Remuneration Policy financial

"includes a proposal for a Remuneration Policy for the Supervisory Board"

A remuneration policy is a company’s written guide on how it pays executives and senior managers, covering salary, bonuses, stock awards and other benefits. It matters to investors because it shows how pay is linked to long-term performance and risk—like a recipe that determines whether incentives encourage sustainable growth or reward short-term gains—affecting governance, shareholder returns and potential conflicts of interest.

Remuneration Report financial

"the 2025 Remuneration Report as included in the Annual Report 2025 (advisory vote)"

A remuneration report is a formal disclosure that lists how much company leaders and board members are paid, including salaries, bonuses, stock awards, pension and other benefits, and explains the rules used to set that pay. Investors use it like a receipt or scorecard to judge whether management’s incentives are aligned with shareholder interests, to estimate ongoing costs, and to spot governance or risk issues that could affect a stock’s value.

forward-looking statements financial

"This release contains certain forward-looking statements with respect to the financial condition"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________________________________________________________________

FORM 6-K

____________________________________________________________________________

REPORT OF FOREIGN ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934

March 30, 2026

____________________________________________________________________________

KONINKLIJKE PHILIPS N.V.

(Exact name of registrant as specified in its charter)

____________________________________________________________________________

Royal Philips

(Translation of registrant’s name into English)

The Netherlands

(Jurisdiction of incorporation or organization)

Prinses Irenestraat 59, 1077 WV Amsterdam, The Netherlands

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒        Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(7): ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐        No ☒

Name and address of person authorized to receive notices and communications from the Securities and Exchange Commission:

M.J. van Ginneken

Koninklijke Philips N.V.

Prinses Irenestraat 59

1077 WV Amsterdam – The Netherlands

This report comprises a copy of the following press release:

“Philips convenes the Annual General Meeting of Shareholders 2026”, dated March 23, 2026.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf, by the undersigned, thereunto duly authorized at Amsterdam, on the 30th day of March 2026.

KONINKLIJKE PHILIPS N.V.

/s/ M.J. van Ginneken
(Chief Legal Officer)

Press Information

March 23, 2026

Philips convenes the Annual General Meeting of Shareholders 2026

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes.

As previously announced, the agenda includes:

•Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.

•Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as members of the Supervisory Board, with effect from May 8, 2026.

•Proposal to re-appoint Roy Jakobs (Dutch/German, 1974) as President/CEO and Chairman and member of the Board of Management, with effect from May 8, 2026.

The agenda furthermore includes a proposal for a Remuneration Policy for the Supervisory Board as well as a number of recurring items, such as the 2025 Remuneration Report as included in the Annual Report 2025 (advisory vote), and the proposals to adopt the company’s financial statements and dividend in cash or shares.

The AGM will be held at the Hotel Okura Amsterdam, Ferdinand Bolstraat 333, Amsterdam on Friday, May 8, 2026, beginning at 10:00 CET.

The complete agenda with explanatory notes, the Annual Report 2025 (which was published on February 19, 2026), the binding nominations, the proposed Remuneration Policy for the Supervisory Board and other information relevant for the AGM have been published here.

For further information, please contact:

Michael Fuchs

Philips Global External Relations

Tel.: +31 614869261

E-mail: Michael.Fuchs@philips.com

Dorin Danu

Philips Investor Relations

Tel.: +31 20 59 77055

E-mail: dorin.danu@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of EUR 18 billion and employs approximately 64,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Forward-looking statements This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.

FAQ

What is Koninklijke Philips (PHG) announcing in this Form 6-K?

Koninklijke Philips is announcing that it has convened its 2026 Annual General Meeting of Shareholders and published the full agenda and explanatory notes. Key items include board appointments, remuneration matters, approval of 2025 financial statements, and a dividend in cash or shares.

When and where will the Philips (PHG) 2026 AGM take place?

The 2026 Philips AGM will be held on Friday, May 8, 2026, starting at 10:00 CET at the Hotel Okura Amsterdam, Ferdinand Bolstraat 333. Shareholders can review the published agenda, explanatory notes, and supporting documents ahead of the meeting.

Which board changes are proposed at the Philips (PHG) 2026 AGM?

Philips proposes appointing John DeFord as a new Supervisory Board member and re-appointing Paul Stoffels, Herna Verhagen, and Sanjay Poonen. It also proposes re-appointing Roy Jakobs as President/CEO, Chairman, and member of the Board of Management, all effective May 8, 2026.

What remuneration items are on the Philips (PHG) 2026 AGM agenda?

The agenda includes a proposed Remuneration Policy for the Supervisory Board and an advisory vote on the 2025 Remuneration Report from the Annual Report 2025. These items outline compensation structures and provide shareholders a voice on pay practices and disclosures.

Will Philips (PHG) shareholders vote on a dividend at the 2026 AGM?

Yes. The agenda includes proposals to adopt Philips’ financial statements and a dividend that can be taken in cash or shares. Specific terms are part of the AGM documents, allowing shareholders to consider payout form alongside overall 2025 performance.

How did Philips (PHG) perform financially in 2025?

Philips generated 2025 sales of EUR 18 billion and operates in more than 100 countries with around 64,800 employees. These figures frame the company’s scale and provide context for AGM decisions on governance, remuneration, and the proposed dividend to shareholders.

What business areas does Philips (PHG) focus on today?

Philips is a health technology company focused on improving health and well-being through innovation. It leads in diagnostic imaging, ultrasound, image-guided therapy, monitoring, enterprise informatics, and personal health, serving both healthcare providers and consumers in hospitals and at home.